Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study

This publication has 16 references indexed in Scilit:

• Effect of Salmeterol and Formoterol in Patients with Chronic Obstructive Pulmonary Disease
  Pulmonary Pharmacology, 1994
• Standards for Bioequivalence of Inhaled Products
  Clinical Pharmacokinetics, 1994
• The effect of increasing doses of β-agonists on airflow in patients with chronic airflow limitation
  Respiratory Medicine, 1993
• Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic.
  Thorax, 1992
• Reversibility tests in chronic obstructive airways disease: their predictive value with reference to benefit from domiciliary nebuliser therapy
  Respiratory Medicine, 1991
• The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta‐ adrenoceptor agonists.
  British Journal of Clinical Pharmacology, 1991
• Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
  Thorax, 1988
• Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects.
  Thorax, 1987
• Assessment of optimum dose of inhaled terbutaline in patients with chronic asthma: The use of simple, cumulative dose-response curves
  Respiratory Medicine, 1982
• 328. Note: The Use of None-Parametric Methods in the Statistical Analysis of the Two-Period Change-Over Design
  Published by JSTOR ,1972